162 related articles for article (PubMed ID: 23981104)
1. Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial.
de Jager J; Kooy A; Schalkwijk C; van der Kolk J; Lehert P; Bets D; Wulffelé MG; Donker AJ; Stehouwer CD
J Intern Med; 2014 Jan; 275(1):59-70. PubMed ID: 23981104
[TBL] [Abstract][Full Text] [Related]
2. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
3. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
Caballero AE; Saouaf R; Lim SC; Hamdy O; Abou-Elenin K; O'Connor C; Logerfo FW; Horton ES; Veves A
Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628
[TBL] [Abstract][Full Text] [Related]
4. Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.
Yngen M; Ostenson CG; Hjemdahl P; Wallén NH
Diabet Med; 2006 Feb; 23(2):134-40. PubMed ID: 16433710
[TBL] [Abstract][Full Text] [Related]
5. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.
Diamanti-Kandarakis E; Paterakis T; Alexandraki K; Piperi C; Aessopos A; Katsikis I; Katsilambros N; Kreatsas G; Panidis D
Hum Reprod; 2006 Jun; 21(6):1426-31. PubMed ID: 16497699
[TBL] [Abstract][Full Text] [Related]
6. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population.
Thorand B; Baumert J; Chambless L; Meisinger C; Kolb H; Döring A; Löwel H; Koenig W;
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):398-405. PubMed ID: 16322530
[TBL] [Abstract][Full Text] [Related]
7. Increased serum vWF and sVCAM-1 levels are associated with late or very late angiographic stent thrombosis after sirolimus-eluting stent implantation.
Jin C; Lu L; Zhu ZB; Zhang RY; Zhang Q; Du R; Ding FH; Chen QJ; Shen WF
Coron Artery Dis; 2010 Aug; 21(5):273-7. PubMed ID: 20508517
[TBL] [Abstract][Full Text] [Related]
8. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
[TBL] [Abstract][Full Text] [Related]
9. Markers of inflammation are inversely related to physical activity and fitness in sedentary men with treated hypertension.
Hjelstuen A; Anderssen SA; Holme I; Seljeflot I; Klemsdal TO
Am J Hypertens; 2006 Jul; 19(7):669-75; discussion 676-7. PubMed ID: 16814119
[TBL] [Abstract][Full Text] [Related]
10. The effect of increased dietary fruit and vegetable consumption on endothelial activation, inflammation and oxidative stress in hypertensive volunteers.
McCall DO; McGartland CP; McKinley MC; Sharpe P; McCance DR; Young IS; Woodside JV
Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):658-64. PubMed ID: 20392617
[TBL] [Abstract][Full Text] [Related]
11. Triglycerides as an early pathophysiological marker of endothelial dysfunction in nondiabetic women with a previous history of gestational diabetes.
Sokup A; Góralczyk B; Góralczyk K; Rość D
Acta Obstet Gynecol Scand; 2012 Feb; 91(2):182-8. PubMed ID: 21954994
[TBL] [Abstract][Full Text] [Related]
12. Positive association of adiponectin with soluble thrombomodulin, von Willebrand factor and soluble VCAM-1 in dyslipidemic subjects.
Vaverkova H; Karasek D; Novotny D; Kovarova D; Halenka M; Slavik L; Frohlich J
Clin Biochem; 2013 Jun; 46(9):766-71. PubMed ID: 23499586
[TBL] [Abstract][Full Text] [Related]
13. Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis.
Bloom BJ; Nelson SM; Eisenberg D; Alario AJ
J Rheumatol; 2005 Feb; 32(2):366-72. PubMed ID: 15693101
[TBL] [Abstract][Full Text] [Related]
14. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
[TBL] [Abstract][Full Text] [Related]
15. Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the MONICA/KORA Augsburg Study.
Thorand B; Baumert J; Döring A; Schneider A; Chambless L; Löwel H; Kolb H; Koenig W
Thromb Haemost; 2006 Jan; 95(1):134-41. PubMed ID: 16543972
[TBL] [Abstract][Full Text] [Related]
16. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
[TBL] [Abstract][Full Text] [Related]
17. Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes.
Lund SS; Tarnow L; Stehouwer CD; Schalkwijk CG; Teerlink T; Gram J; Winther K; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
Eur J Endocrinol; 2008 May; 158(5):631-41. PubMed ID: 18426821
[TBL] [Abstract][Full Text] [Related]
18. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
Schaumberg DA; Glynn RJ; Jenkins AJ; Lyons TJ; Rifai N; Manson JE; Ridker PM; Nathan DM
Circulation; 2005 May; 111(19):2446-53. PubMed ID: 15867184
[TBL] [Abstract][Full Text] [Related]
19. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection.
Kayal S; Jaïs JP; Aguini N; Chaudière J; Labrousse J
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):776-84. PubMed ID: 9517590
[TBL] [Abstract][Full Text] [Related]
20. The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial.
Caballero AE; Delgado A; Aguilar-Salinas CA; Herrera AN; Castillo JL; Cabrera T; Gomez-Perez FJ; Rull JA
J Clin Endocrinol Metab; 2004 Aug; 89(8):3943-8. PubMed ID: 15292331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
